Cargando…

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

Rosuvastatin, is a widely-used statin for the treatment of hypercholesterolemia and the prevention of cardiovascular diseases. Although rosuvastatin is well tolerated, about 3/10.000 patients can suffer severe myopathy. Rhabdomyolysis is a severe medical condition that causes injury to the skeletal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calderon-Ospina, Carlos Alberto, Hernández-Sómerson, Mario, García, Ana María, Mejia, Adriana, Tamayo-Agudelo, Caroll, Laissue, Paul, Fonseca Mendoza, Dora Janeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060025/ https://www.ncbi.nlm.nih.gov/pubmed/32184647 http://dx.doi.org/10.2147/PGPM.S228709

Ejemplares similares

Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population
por: Ramírez, Brian, et al.
Publicado: (2019)

Rosuvastatin-Induced Rhabdomyolysis: A Case Report
por: Nikalji, Ravindra, et al.
Publicado: (2021)

A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy
por: Angulo-Aguado, Mariana, et al.
Publicado: (2021)

Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin
por: Anklesaria, Zafia, et al.
Publicado: (2020)

Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
por: Wang, Wen, et al.
Publicado: (2022)

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
por: Sakurama, Keiki, et al.
Publicado: (2023)

Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations
por: Parada-Márquez, Juan Fernando, et al.
Publicado: (2023)

Correction to: Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
por: Sakurama, Keiki, et al.
Publicado: (2023)

Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy
por: Calderon-Ospina, Carlos Alberto, et al.
Publicado: (2020)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Optimum polygenic profile to resist exertional rhabdomyolysis during a marathon
por: Del Coso, Juan, et al.
Publicado: (2017)

Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype
por: Fonseca, Dora Janeth, et al.
Publicado: (2021)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
por: Simona, Aurélien, et al.
Publicado: (2023)

Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin Use: A Case Report
por: Chitralli, Deepak, et al.
Publicado: (2020)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
por: Maslarinou, Anthi, et al.
Publicado: (2023)

Polygenic dissection of the bipolar phenotype
por: Hamshere, M. L., et al.
Publicado: (2011)

Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
por: Zhai, Song, et al.
Publicado: (2022)

Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report
por: Mitaritonno, Michele, et al.
Publicado: (2021)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
por: Duconge, Jorge, et al.
Publicado: (2021)

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia
por: Ruderfer, Douglas M., et al.
Publicado: (2013)

Dissecting Polygenic Etiology of Ischemic Stroke in the Era of Precision Medicine
por: Li, Jiang, et al.
Publicado: (2022)

THBD sequence variants potentially related to recurrent pregnancy loss
por: Quintero-Ronderos, Paula, et al.
Publicado: (2017)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Dissecting the precise nature of itch-evoked scratching
por: Wimalasena, Nivanthika K., et al.
Publicado: (2021)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Rosuvastatin induced photolocalized purpura
por: Thabouti, Marwa, et al.
Publicado: (2022)

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
por: Ren, Yizhi, et al.
Publicado: (2017)

An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
por: Uz, Burak, et al.
Publicado: (2015)

Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam
por: Rastogi, Vaibhav, et al.
Publicado: (2018)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis
por: Valdés-Garicano, Mónica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2p0sjbrag5qvg1v11298a4o46